arrow
X

Xishan Wang

chinese academy of medical sciences - peking union medical college
H指数:11
被引数:747

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lymph nodes molecular subtypes unravel lymph nodes heterogeneity and clinical implications in colorectal cancer

淋巴结分子亚型揭示了淋巴结异质性与结直肠癌的临床意义

2025-08-220
OAAI
Chemotherapy alone versus chemotherapy plus targeted therapy as adjuvant therapy for initially unresectable colorectal cancer liver metastases: a multicenter cohort study

化疗单独与化疗联合靶向治疗作为初始不可切除的结直肠癌肝转移的辅助治疗:一项多中心队列研究

2025-01-110
OA
RATIONALE-304 long-term outcomes: First-line tislelizumab (TIS) plus chemotherapy (chemo) vs chemo for locally advanced or metastatic non-squamous (NSQ) NSCLC

RATIONALE-304长期结局:局部晚期或转移性非鳞状(NSQ)非小细胞肺癌(NSCLC)中,一线替雷利珠单抗(TIS)联合化疗(chemo)与化疗(chemo)的对比。

2024-12-010
PRE
Exploratory biomarker analysis of phase III ASTRUM-004 study: Serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer

III期ASTRUM-004研究探索性生物标志物分析:Serplulimab联合化疗作为晚期鳞状非小细胞肺癌的一线治疗

2024-09-010
PRE
S-1 Based Simultaneous Integrated Boost Radiotherapy Followed by Consolidation Chemotherapy with S-1 for Esophageal Squamous Cell Carcinoma in the Elderly - A Multicenter Phase II Study (3JECROG P-01)
2019-09-010
PREAI